Financial Architects, Inc Abb Vie Inc. Call Options Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $25,192 - $30,288	400 Added 200.0%	600 $45,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $30,856 - $36,316	-400 Reduced 66.67%	200 $16,000
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $71,128 - $79,072	-800 Reduced 57.14%	600 $57,000
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $128,814 - $172,494	1,400 New	1,400 $133,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.